This Review published in NatureBiotech discusses cuttingedge developments in engineering immune cells towards expanding the reach and efficacy of adoptive cell therapies in cancer and beyond. httpsgo.nature.com2wDF8VZÂpic.twitter.comEv1F7fy8lU
This Review, published in @NatureBiotech, discusses cutting-edge developments in engineering immune cells towards expanding the reach and efficacy of adoptive cell therapies in cancer and beyond. https://go.nature.com/2wDF8VZ pic.twitter.com/Ev1F7fy8lU
More From BioPortfolio on "This Review, published in @NatureBiotech, discusses cutting-edge developments in engineering immune cells towards expanding the reach and efficacy of adoptive cell therapies in cancer and beyond. https://go.nature.com/2wDF8VZ pic.twitter.com/Ev1F7fy8lU"